Climb Bio, Inc. (CLYM) Tops Q1 EPS by 9c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Select Medical stockholders approve buyout by insider-led consortium
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance